Liquidia Corporation Common Stock vs Palo Alto Networks Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B), while Palo Alto Networks Inc trades at $370.58 (market cap $324.77B). The key difference: Palo Alto Networks Inc is far larger — about 135.3× Liquidia Corporation Common Stock's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Palo Alto Networks Inc for 82 Days on average.
| LQDA | PANW | |
|---|---|---|
Market Cap | $2.40B | $324.77B |
Volume | 2,857,547 | 3,473,783 |
Sector | Health | Technology |
52-Week High | $91.03 | $419.91 |
52-Week Low | $22.02 | $141.67 |
Typical Hold Time | 0 Days | 82 Days |
Enterprise Value | $2.30B | $324.20B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Palo Alto Networks (PANW) trades at $375.04, down 7.13% over the past day but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive sentiment from 64 buy ratings. Recent earnings beats and robust revenue growth to $9.22B in 2025 highlight fundamental strength, though valuation ratios remain elevated with a P/E of 992.58. The company's AI-driven security platform and continuous defense services are key growth drivers, positioning it well in the cybersecurity sector.
Outlook: PANW's AI integration and platformization strategy support long-term growth, with a consensus price target of $400.05 offering ~6.7% upside. Risks include premium valuation, rising costs, and competitive pressures. Investors should weigh strong fundamentals against high multiples.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →